A Single Arm, Prospective, Multi-Center Study to Evaluate Safety and Efficacy of Isavuconazole for Primary Treatment of Chinese Patients With Invasive Fungal Disease (IFD) Caused by Aspergillus Species or Other Filamentous Fungi soansm01 Fri, 03/20/2026 - 06:01 Cresemba® Isavuconazonium Sulfate PHASE IV Tue, 02/07/2023 - 12:00 Fri, 04/11/2025 - 12:00 NCT05630976 C3791001 Public Disclosure Synopsis .pdf (138.68 KB) N https://clinicaltrials.gov/study/NCT05630976?term=C3791001&viewType=Card&rank=1 C3791001